Navigation Links
China Biologic Products Announces Third Quarter 2008 Results Conference Call
Date:11/11/2008

TAI'AN CITY, Shandong, China, Nov. 11 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that it will host a conference call at 10:00 a.m. EST on Thursday, November 13, 2008, to discuss the third quarter 2008 results.

Hosting the call will be Mr. Colin Zhao, Chief Executive Officer, and Mr. Tristan Kuo, Chief Financial Officer. The Company plans to release its earnings on November 12, 2008.

To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 888- 339-2688. International callers should dial 617-847-3007. The pass code for the call is 320 762 60.

If you are unable to participate in the call at this time, a replay will be available for 14 days starting on Thursday, November 13, 2008 at 12:00 p.m. EST. To access the replay, dial 888-286-8010, international callers should dial 617-801-6888. The conference pass code is 14755104.

About China Biologic Products, Inc.

Through its indirect majority-owned subsidiary Shandong Taibang Biological Products Co. Ltd., China Biologic Products, Inc. (the "Company"), is principally engaged in the research, development, production and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. The Company's human albumin products are mainly used to increase blood volume, and its immunoglobulin products are used for the treatment and prevention of diseases.

For more information, please contact:

Company Contact:

Mr. Y. Tristan Kuo

CFO

China Biologic Products, Inc.

Tel: +86-538-620-2206

Email: IR@chinabiologic.com

Web: http://www.chinabiologic.com

Investor Relations Contact:

Mr. Crocker Coulson

President

CCG Investor Relations

Tel: +1-646-213-1915 (NY office)

Email: crocker.coulson@ccgir.com

Web: http://www.ccgirasia.com


'/>"/>
SOURCE China Biologic Products, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics, Inc. Reports Second Quarter 2009 Financial Results
2. China Clean Energy Resumes Biodiesel Production After Temporary Halt
3. China Medicine Announces Conference Call to Discuss Third Quarter 2008 Results
4. Yongye Biotechnology to Present at Roth Capital China Comes to Vegas Conference
5. China Sky One Medical, Inc. Announces Conference Call to Discuss Third Quarter 2008 Results
6. China Pharma Holdings, Inc. to Present at Two Upcoming U.S. Investor Conferences
7. China Yingxia to Present at Roth China Comes to Vegas Conference
8. PAREXEL Expert to Address Key Aspects of Conducting Clinical Trials in China at 7th Annual Partnerships in Clinical Trials Congress
9. Sinovac Named to Deloitte Technology Fast 50 China
10. Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China
11. China Medical Technologies Announces Reporting Dates for the September Quarter Results and Addresses Investor Inquiries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... February 21, 2017 , ... During ... connected digital health applications, announced a partnership with Redox, a leader in cloud-based ... to many clinical systems while keeping data secure in the cloud. , The ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... Treximo will pair its $200M operational capacity with its strategic internal leadership ... in areas affecting quality and operational management. With office locations in ...
(Date:2/21/2017)... , Feb. 21, 2017   Logicalis Healthcare Solutions ... IT solutions and managed services provider ( www.us.logicalis.com ), ... Desk for Epic. The new service will help hospital ... resources by giving physicians, nurses and other clinicians immediate ... tier-one support. This will allow hospital IT staff to ...
(Date:2/20/2017)... - BioAmber Inc. (NYSE: BIOA ) announced today that Jean-Francois ... the company,s COO, has been named President, effective immediately.  ... Fabrice has overseen the construction, start-up and operation of the manufacturing ... the Mitsui JV.  Fabrice has also been extensively involved in the ... ...
Breaking Biology Technology:
(Date:2/16/2017)... 16, 2017  Genos, a community for personal ... has received Laboratory Accreditation from the College of ... to laboratories that meet stringent requirements around quality, ... processes. "Genos is committed to maintaining ... We,re honored to be receiving CAP accreditation," said ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- ... platform that is designed to enhance fraud detection ... release in the RSA Fraud & Risk Intelligence ... organizations to leverage additional insights from internal and ... to better protect their customers from targeted cybercrime ...
(Date:2/10/2017)... DUBLIN , Feb 10, 2017 ... PharmaBiotech,s new report "Personalized Medicine - Scientific and Commercial ... ... in personalized medicine. Diagnosis is integrated with therapy for selection ... emphasis on early detection and prevention of disease in modern ...
Breaking Biology News(10 mins):